CMT is the most common hereditary neuromuscular disorder of the peripheral nervous system 24 with a prevalence of 1/2500 individuals and it is caused by mutations in more than 80 genes. 25 LRSAM1, a RING finger ubiquitin ligase also known as TSG101-associated ligase (TAL), has 26 been associated with Charcot-Marie-Tooth disease type 2P (CMT2P) and to date eight causative 27 mutations have been identified. Little is currently known on the pathogenetic mechanisms that 28 lead to the disease. We investigated the effect of LRSAM1 deregulation on possible LRSAM1 29 interacting molecules in cell based models. Possible LRSAM1 interacting molecules were 30 identified using protein-protein interaction databases and literature data. Expression analysis of 31 these molecules was performed in both CMT2P patient and control lymphoblastoid cell lines as 32 well as in LRSAM1 and TSG101 downregulated SH-SY5Y cells.TSG101, UBE2N, VPS28, EGFR 33 and MDM2 levels were significantly decreased in the CMT2P patient lymphoblastoid cell line as 34 well as in LRSAM1 downregulated cells. TSG101 downregulation had a significant effect only on 35 the expression of VPS28 and MDM2 and it did not affect the levels of LRSAM1. This study 36 confirms that LRSAM1 is a regulator of TSG101 expression. Furthermore, deregulation of 37 LRSAM1 significantly affects the levels of UBE2N, VPS28, EGFR and MDM2. 38 39 Keywords: LRSAM1, TSG101, interacting molecules, CMT2P 40 41 42 43 44 45
Introduction 47
Charcot-Marie-Tooth (CMT) disease is the most common inherited neuropathy, characterized by 48 peripheral nervous system degeneration, with a relatively high frequency (1:2,500 individuals) (1, 49 2). CMT disease is classified into demyelinating, axonal and intermediate types based on 50 electrophysiological findings (3). It is further sub-divided into an increasing number of genetic 51 subtypes with more than 80 CMT genes currently known. 52
Leucine Rich Repeat And Sterile Alpha Motif Containing 1 (LRSAM1) has been associated with 53
Charcot-Marie-Tooth disease type 2P (CMT2P). LRSAM1, is a RING finger ubiquitin ligase, 54 which participates in a range of functions, including cell adhesion, signaling pathways and cargo 55 sorting through receptor endocytosis (4, 5) . It is a multidomain protein with an N-terminal 56 leucine-rich repeat (LRR) domain, followed by an Ezrin-Radixin-Moezin (ERM) domain, a 57 coiled-coil (CC) region, a SAM domain, a PSAP/PTAP tetrapeptide motif and a RING finger 58 domain (6). LRSAM1, also known as TAL (TSG101-associated ligase), regulates the metabolism 59 of TSG101 (Tumor Susceptibility gene 101) by polyubiquitination (7) . TSG101 is a tumor 60 suppressor gene component of the ESCRT machinery (Endosomal Sorting Complex Required for 61 Transport), with a significant role in cell cycle regulation and differentiation (5, 8) . LRSAM1 62 binds to TSG101, through a bivalent binding of the PTAP motif and the CC domain of LRSAM1 63 (5, 9) . After binding, LRSAM1 attaches several monomeric ubiquitins to the C-Terminal of 64 TSG101, thus regulating its function. LRSAM1 mutations impair the LRSAM1-TSG101 65 interaction (10). 66
We identified a dominant LRSAM1 mutation (c.2047-1G>A, p.Ala683ProfsX3) located in the 67 RING finger domain of LRSAM1 (11) . Recently, we reported that downregulation of LRSAM1 68 affects the proliferation and morphology of neuroblastoma SH-SY5Y cells, and, overexpression 69 of wild-type LRSAM1 rescues, while the c.2047-1G>A mutant fails to rescue the phenotype of the cells (12). To date, eight LRSAM1 mutations have been associated with CMT neuropathy, seven 71 of them associated with dominant and one with recessive inheritance (13) . 72
In order to study the role of LRSAM1 and the effect of the c.2047-1G>A mutant E3 ligase 73 domain, we identified molecules that possibly interact with LRSAM1. Expression levels of 74 selected molecules were evaluated in the LRSAM1 c.2047-1G>A CMT2P patient lymphoblastoid 75 cell line and also in LRSAM1 knocked down SH-SY5Y cells. Since, TSG101 is the only currently 76 well characterized interactor of LRSAM1 (5), we also performed TSG101 downregulation in SH-77 SY5Y cells and evaluated the levels of selected molecules in these cells as well. 78
Results

79
Deregulation of LRSAM1 affects TSG101 expression 80
Since TSG101 is an already known interactor of LRSAM1, we evaluated TSG101 levels in the 81 CMT2P patient lymphoblastoid cell line. Western blot analysis of the CMT2P patient and control 82 lymphoblastoid cell lines confirmed the presence of the wild-type and the mutant truncated 83 LRSAM1 proteins in the patient sample, as previously reported (4), and revealed a more than 84 50% reduction of TSG101 levels in the patient lymphoblastoid cell line as compared with the 85 controls ( Figure 1) . 86
With another approach, double transfection of LRSAM1 siRNA in neuroblastoma SH-SY5Y cells 87 caused a >70% decrease of LRSAM1 levels which also resulted to an approximately 50% 88 reduction of TSG101 levels. Double transfection of TSG101 siRNA caused a 70% decrease on 89 TSG101 levels, while it did not affect the LRSAM1 levels ( Figure 2) . 90 91 Protein-protein interaction network extraction of LRSAM1 possibly interacting molecules 92 TSG101, UBE2N, VPS28, EGFR and MDM2 that possibly interact with LRSAM1 were identified 93 using the protein-protein interaction database STRING ( Figure 3 ) and IntAct. After literature based evaluation these molecules were selected for further analysis. Furthermore, the AP-3 was 95 selected for analysis since in a recent study LRSAM1 immunoprecipitated with . 96
97
RNA expression analysis of interacting molecules in lymphoblastoid cell lines 98
We investigated RNA expression of candidate interacting molecules (TSG101, UBE2N, VPS28, 99 EGFR, MDM2 and AP-3) in the CMT2P patient and control lymphoblastoid cell lines. mRNA 100 levels of TSG101, UBE2N, VPS28, MDM2 and EGFR were significantly reduced in the patient 101 lymphoblastoid cell line as compared to the control, while AP-3 presented an equal expression in 102 both patient and control lymphoblastoid cell lines. Specifically, the patient sample showed 103 significantly lower mRNA levels of TSG101 (43%), UBE2N (45%), VPS28 (32%), EGFR (41%) 104
and MDM2 (35%) as compared to the control sample. In contrast AP-3 (98%) showed a similar 105 expression between the patient and control samples ( Figure 4) . 106 107 RNA expression analysis of interacting molecules in LRSAM1 or TSG101 downregulated 108
SH-SY5Y cells 109
RNA expression of the above candidate molecules was evaluated in LRSAM1 or TSG101 110 downregulated cells as well. Ninety-six hours after the first LRSAM1 siRNA transfection, we 111
observed an approximately 70% reduction of endogenous LRSAM1 RNA levels, reproducing the 112 previously reported effect (5). Downregulation of LRSAM1 also caused a significant decrease in 113 approximately 50% of TSG101, UBE2N, VPS28, MDM2 and EGFR expression. In agreement 114 with findings in the patient derived lymphoblastoid cell line, AP-3 levels were not affected by the 115 LRSAM1 downregultion. Ninety-six hours after the first TSG101 siRNA transfection, we 116
observed an approximately 70% reduction of endogenous TSG101 RNA levels. Downregulation 117 of TSG101 caused an approximately 50% reduction of VPS28 and a 20% decrease of MDM2 118 levels. Normal levels of LRSAM1, UBE2N, EGFR and AP-3 were observed after TSG101 down regulation ( Figure 5 ). Although, LRSAM1 downregulation caused a significant reduction of 120 TSG101 levels (55%), TSG101 downregulation did not affect the expression of LRSAM1. 121
Discussion
122
LRSAM1 has been associated with CMT disease and currently its role in neurodegenerative 123 disorders and in CMT pathogenesis is still unclear. In the present study we found that 124 deregulation of LRSAM1 impaired TSG101, UBE2N, VPS28, MDM2 and EGFR levels. TSG101 125 downregulation had an effect on VPS28 and MDM2 levels. 126
The E3 ligase activity of LRSAM1 performs ubiquitination of TSG101, regulating its expression 127 (5). TSG101 levels are also modulated by other mechanisms beyond LRSAM1 E3 regulation. 128 MDM2, another E3 ligase, shares an autoregulatory loop with TSG101 (15). TSG101 prevents its 129 ubiquitination and increases the levels of MDM2 thus promoting ubiquitin degradation of p53 130 (15, 16). Over expression of truncated TSG101 in U20S cells caused reduction of MDM2 levels 131 (15), while over expression of normal TSG101 doubled the short half-life of MDM2 and elevated 132 its expression levels (15). Notably we detected that 70% downregulation of LRSAM1 caused 133 55% decrease in TSG101 and also 55% decrease in MDM2, whereas 70% downregulation of 134 TSG101, which did not affect LRSAM1, caused only 20% decrease in MDM2 expression. These 135 results indicate that TSG101 exerts a small effect on MDM2 expression (20%) relative to the 136 effect of LRSAM1 (55%), the later through an unknown mechanism. 137 Interaction of TSG101 (yeast VPS23) with VPS28, VPS37 and MVB12 is necessary for the 138 formation of the . Binding between TSG101 and ESCRT-I subunits 139 protects TSG101 degradation (9). VPS28 binds to the C-Terminal of TSG101 and blocks the 140 interaction with LRSAM1, thus subsequently decreases the ubiquitination of TSG101 (18). 141
Reduced levels of VPS28 were observed in cells that lack TSG101 (18), while over expression of 142 VPS28 did not affect the levels of TSG101 (9). In our study, we observed decreased levels of VPS28 in the CMT2P patient lymphoblastoid cell line and showed that down regulation of 144 LRSAM1 or TSG101 caused a significant reduction in VPS28 levels. It is thus possible that 145 mutant or knockdown LRSAM1 affects VPS28 levels directly or through the impaired TSG101 146 levels. TSG101 and/or VSP28 deficiency possibly affect the formation of the ESCRT-I complex. 147
The ESCRT-I complex along with ESCRT-0, ESCRT-II and ESCRT-III form the endosomal 148 sorting complexes required for transport (ESCRTs). Each ESCRT complex, consists of VPS 149 proteins, and regulates biogenesis of the Multivesicular Body (MVB) and cargo sorting within the 150 lysosomes. Besides endocytic trafficking, tumor suppression, autophagy, miRNA function and 151 cancer, the ESCRT has been associated with neurodegenerative diseases (19, 20) . In the central ubiquitinated protein accumulation (20) . It is thus possible that dysregulation of any ESCRT 158 complex can affect the normal function of the ESCRT machinery and the central nervous system. 159
We observed a decreased expression of UBE2N in the patient lymphoblastoid cell line and also in 160 LRSAM1 downregulated cells. A recent study showed, using a ubiquitination assay, that 161 LRSAM1 interacts with UBC13, a mouse homolog of UBE2N and that mutations of LRSAM1 162 prevent this interaction, abolishing the ubiquitination activity of LRSAM1(10). UBE2N belongs 163 to the family of Ubiquitin-conjugating enzymes (E2) and it is the only known enzyme that 164 facilitates the creation of K63-linked polyubiquitination chains on proteins which are selected for 165 proteasomal degradation (22, 23) . E2 along with E1 and E3 enzymes consist the UPS system 166 which removes the misfolded and abnormal proteins within the cells. Alzheimer, Parkinson and 167
Huntington neurodegenerative diseases are caused by the formation of inclusions in the brain because of the accumulation of misfolded proteins in neurons (23), indicating a possible 169 pathogenic role of the UPS system in neurodegeneration. Expression of UBE2N was found to be 170 elevated in synaptosomes in tissues obtained from aged monkey brain while UPS activity was 171 found to be depressed. The increased level of UBE2N in aged monkey brain or the over 172 expressed UBE2N in HEK293 cells, caused the accumulation of mutant huntingtin (HTT). In 173 contrast, the decreased level of UBE2N in aged monkey brain, HEK293 and PC12 cells caused 174 reduction of mutant HTT accumulation (23). Knockdown of UBE2N in Parkin transfected HeLa 175 cells inhibited the K63-linked polyubiquitination at mitochondrial sites suggesting a contribution 176 of UBE2N in Parkin-mediated mitophagy (24). 177
The RING finger domain of LRSAM1 also plays a role in the regulation of EGFR expression (5). 178
We observed that the LRSAM1 c.2047-1G>A mutation, located in the RING finger domain, 179 results in impaired EGFR expression. Transfection of an inactive mutant-RING LRSAM1 has 180 been reported to lead to the reduction of EGFR expression, while transfection of wild type 181 LRSAM1 improved EGFR expression (5). Also in the presence of mutant TSG101 in NIH 3T3 182 and SL6 cells, EGFR moved from the early endosomes and MVBs to the plasma membrane for 183 recycling (25). In our study, downregulation of TSG101 did not affect the expression of EGFR. 184
The EGF receptor is a family member of the ErbB receptors of kinases and regulates essential 185 signaling pathways including cell proliferation and differentiation, cell cycle and migration (26) . 186
Upregulation of EGFR has been associated with both oncogenesis and neurodegeneration. 187
Expression of EGFR is activated in many malignancies such as breast cancer, prostate cancer and 188 gliomas (27) AP-3 has been reported to form a heterotetrameric complex, targeting cargos of lysosomes and 193 lysosome related organelles (29). Recently LRSAM1 was identified as an AP-3 interactor, 194 because it immunoprecipitated with AP-3. It has been proposed, that while LRSAM1 is bound to 195 AP-3, it regulates the ESCRT-I sorting function, by ubiquitinating certain cargoes (14). We found 196 normal expression of AP-3 in the CMT2P patient lymphoblastoid cell line as well as after 197 LRSAM1 downregulation in SH-SY5Y cells. These data, suggest that the interaction between the 198 two molecules is probably controlled by AP-3 and not LRSAM1. 199
In conclusion, we confirm that TSG101 expression is regulated by LRSAM1. Decreased levels of 200 UBE2N and EGFR were observed only after LRSAM1 knockdown thus indicating that these two 201 molecules are regulated by a mechanism in which only LRSAM1 is involved. Decreased 202 expression of VPS28 and MDM2 after either LRSAM1 or TSG101 downregulation demonstrates 203 that the levels of these two molecules are regulated by a mechanism in which both LRSAM1 and 204 TSG101 may be involved. Further investigation of the above molecules may enable delineation of 205 the pathways that lead to CMT2P pathology. 206
Materials and Methods
207
In this study, we selected possible LRSAM1 interacting molecules and investigated their 208 expression levels in lymphoblastoid cell lines as well as in LRSAM1 and TSG101 downregulated 209 neuroblastoma SH-SY5Y cells. 
Whole human LRSAM1 constructs 227
The pIRES2-EGFP-LRSAM1 wild-type and mutant constructs were purchased from Eurofins 228 (Germany) as previously descripted (12). The mutant LRSAM1 cDNA construct included a G 229 base deletion at the first base of exon 25, creating the frame shift at the RNA level (11). 230 231
Downregulation of LRSAM1or TSG101 in neuroblastoma SH-SY5Y cells 232
Transfections were performed using the Lipofectamine® 3000 (C3019H, Life Technologies, 233 U.S.A.) The siRNAs against LRSAM1 or TSG101 (Life Technologies, USA) were double-234 transfected into SH-SY5Y cells as previously descripted (12) 
Protein-protein interaction database 243
In silico analysis was carried out using the STRING9.05&10.0 (http://string-db.org/) and IntAct 244 (http://www.ebi.ac.uk/intact/) databases. Extracted LRSAM1 possibly interacting molecules were 245 selected for RNA expression analysis after literature evaluation. 
RNA expression levels 256
Expression levels of TSG101, UBE2N, VPS28, MDM2, EGFR and AP-3 were evaluated by 257 cDNA PCR amplifications. At least two sets of primers specific for each molecule and also for 258 the GAPDH housekeeping gene were used. For each set of primers a standard curve was plotted 259 in order to define the optimum number of PCR reaction cycles that fall within the exponential 260 phase of the amplification reaction ( Supplementary Figure 1, available upon request) . RNA levels 261 of the patient and control samples as well as of the LRSAM1 and TSG101 knocked down cells 262 were normalized using the GAPDH housekeeping RNA levels. Gel bands were measured using 263 the ImageJ analysis software. 264 265 266 267
Protein extraction from experimental SH-SY5Y cells and lymphoblastoid cell lines 268
Proteins were extracted using a protein lysis buffer, that contained 1M NaCl, 10mM Tris-Cl 269 (pH=7.5), 10% glycerol (G5516, Sigma-Aldrich, U.S.A), 1% Tween TM 20 (Affymetrix, U.S.A.) , 270 10Mm β-Mercaptoethanol (Sigma-Aldrich, U.S.A) and 1x EDTA-free Protease Inhibitor Cocktail 271 (Promega, U.S.A.). Cell lysates were centrifuged at 4°C and supernatants were collected. Lysates 272 were sonicated and denatured at 95°C. Then proteins were diluted in 1x Sodium Dodecyl Sulfate 273 20% (ThermoFisher Scientific, U.K.). The Coomassie Plus (Bradford) protein assay (23236, 274 ThermoFisher Scientific, U.K.) was used to determine the protein concentration. 275 276
Western blot analysis 277
Proteins were loaded and separated onto SDS-PAGE 12% polyacrylamide gels and were 278 transferred to Hybond-P hydrophobic polyvinylidene difluoride (PVDF) membranes (Millipore, 279 Germany). Membranes were blocked for 1 hour at room temperature and were incubated 280 overnight at 4°C with the respective specific primary antibody for each protein [mouse anti-281 LRSAM1/Abcam ab73113 (1:400), rabbit anti-LRSAM1/Novus Biological H00090678-D01 282
(1:750), mouse anti-TSG101/Novus Biological NB200-11 (1:500) and mouse anti-β-283 ACTIN/Sigma-Aldrich A2228 (1:4000)]. Then, incubation with the appropriate secondary 284 antibodies was performed for 2 hours and followed by incubation with the visualization 285
LumiSensor TM Chemiluminescent HRP Substrate Kit (Genscript, U.S.A.) at room temperature. 286
Membranes were visualized using the UVP imaging system (BioRad, U.S.A.). Quantification of 287
Western blots was performed using the ImageJ program (https://imagej.nih.gov). The protein 288 quantity ratio was estimated relative to β-Actin. 
Statistical analysis 294
Quantitative data (ratio %) from three independent experiments were analyzed using the two-295 tailed Student's paired t-test. Thresholds of P-value < 0.05 were considered statistically 296 significant. All the data are expressed as the mean% ± standard deviation (SD) from three 297 independent experiments. The mean of quantitative data of the control samples was set to 100%. 
418
Specifically, the patient lymphoblastoid cell line showed significantly lower levels of TSG101 (43% ±0.28%, 419 p<0.005), UBE2N (45%±0.97%, p<0.0109), VPS28 (32%±3.28%, p<0.031), EGFR (41%±1.88%, p<0.012) and 420 MDM2 (35%±2.01%, p<0.025) than the control sample. In contrast AP-3 (98%±3.47%, p<0.041) showed similar 421 expression between the patient and control. Amplification of each primer set was repeated in triplicate. 
423
Quantification of the RNA expression levels of the interacting molecules relative to the Untransfected control cells,
424
which was set to 100 96h after the first siRNA transfection. Values were obtained as ratios of the RNA of interest 425 over GAPDH control. Specifically, LRSAM1 downregulation significantly decreased the levels of LRSAM1 (30% 426 ±3.86%, p<0.0275), TSG101 (45% ±2.19%, p<0.0092), UBE2N (52%±3.05%, p<0.0158), VPS28 (47%±3.62%, 427 p<0.0336), EGFR (49%±3.38%, p<0.0125) and MDM2 (45%±2.44%, p<0.0096) compared to the Untransfected 428 control cells. In contrast, AP-3 (96%±2.59%, p<0.0109) showed similar expression between the LRSAM1 knocked 429 down and Untransfected cells. TSG101 downregulation significantly decreased the levels of TSG101 (33%
